siRNA treatment lowers triglycerides in people with rare ailment
.ANALYSIS FEATURE.19 September 2024.
Plozasiran lessened triglyceride degrees by 80% and lowered the danger of pancreatitis in clients along with constant chylomicronemia, along with or even without a hereditary diagnosis.